R E C O M D I N A N T E R Y T I I R O P O I E T I N (rhEPO) R E D U C E S T H E N E E D F O R
of Berlin, Germany. The anaemias o f prematurity are characlerizcd by inadequate erytliropoietin response and require freyuenc transfusions. hlell~ods: I n a 12 centre blinded tri;il. V L B W infants were ran om~zed ~ntr) rhEPO ( n = 120) or control group ( n = 121) on da 3 o f lifc. Dlindin wa\ enwred hy two indcpenderlt tc;inis ~n cach centre. r h E~& was given 3 x 251 llJ/kgjwcek s.c. from cI:I~ 3 to clay 42 of life (17 single doses). Oral Iron startcd in both grr~ups on day 14 WIIII 2 In 9)da .!lid was ;idju)ltcd :lccording to serum fcrritin teve~s. Results: ~< c~i c u~o c y t c (~~f ; I n J l ; c u t r o~,~l i~ counts 635. The present study was undertaken to study the effect of oxygen exposure on lung hyaluronan concenlration and lung water in rabbit pups born at ternl. Some pups were kcpt in oxygen and some were kcpt in air. I'ups were sacrificed and lungs were taken nt an age of 4-6 days. Tlic walcr contenl was ~ilwsurcd as wclldry wclghl, and Ihe hyaluronan concenlration wit11 a r;ldlo~l~ctric assny kit ( [ [ A 50, l ' l~n r~~i n c~a , Ullp,nl;~). Rcsulls: In the lu~igs from pups kept in oxygen significantly higher hyaluronan concentrations werc seen both at 4 (p<O.IXIl;n= 14) and 6 (p<0.01;11= 17) d;~ys o f age compared to the lungs from the pups kept in air (n=l5 and 29, respectively).
This was accompanied by a higher lung waler conlcnt (p<0.001) than in pups kept in air at 4 dnys of age. Conclusion: I n tcrlil rabbit pups lurig I~y;\luro~i;~n co~iccritr;~t~on ;~nd lung \r..llcr conlent 1ncrc.u during oxygcn expolure.
PCRSISTEIIT PULMONARY IIYPERTLIISION OF TllE NEWBORN (PPHN) I S SELECTIVELY LOWERED DY PROSTACYCLIN ( P C ) . , M a r l a n n e E r o n e n . M a l l a P o h 3 a v u o r l .
E r k k l P e s o n e n . S t u r e A n d e r s s o n . K u l 0 . R a i v i p . C h i l d r e n ' s H o s p i t a l a n d D e p a r tm e n t o f ObIGyn, U n i v e r s i t y o f H e l s i n k i , F i n l a n d .
PPHN i s a common i n d i c a t i o n f o r ECMO b e c a u s e o f s e v e r e h y p o x e m i a a n d m o r t a l i t y r i s k . We s t u d i e d t h e e f f e c t s o f PC
i n 0 i n f a n t s ( b . w t . 2 5 4 0 -4 1 3 0 g, g e s t . a g e 34-42 wk) w i t h r e s p i r a t o r y f a i l u r e a n d PPHN. A t mean a g e 1 9 ( r a n g e 3-32) h, d e s p i t e m a x i m a l v e n t i l a t o r t h e r a p y a n d F i 0 2 o f 1 . 0 , mcan pa021PA02 was 0.07 ( r a n g e 0 . 0 4 -0 . 1 0 ) a n d AaDO2 614 ( 5 2 1 -6 4 0 ) mmHg. Mean p u l m o n a r y a r t e r y p r e s s u r e (PAP) b y e c h o c a r d i og r a p h y was 68 ( 6 4 -8 0 ) a n d s y s t e -m i c p r e s s u r e (DP) 59 ( 5 1 -6 4 ) mmHg. A f t e r v o l u m e c o r r e c t i o n a n d d u r i n g d o p a m i n e i n f u s i o n , PC was i n c r e a s e d s t e p w i s e f r o m a mean o f 1 0 t o 5 5 (max. 1 2 0 ) n g / k g / m i n i n 4-12 h, a t w h i c h t i m e PAP h a d d e c r e a s e d t o 49 ( 4 5 -5 5 ) a n d DP t o 53 ( 4 2 -6 3 ) mmllg, PAP t h e r e a f t e r r e m a i n i n g b e l o w BP. A f t e r 7 2 h PAP Was 50 ( 2 5 -8 6 ) , BP 66 ( 5 5 -7 2 ) , paO2lPA02 0.14 (0.08-0.40), a n d AaDO2 429 ( 8 3 -6 0 5 ) a t F i 0 2 o f 0 . 5 9 . A l l p a t i e n t s s u r v i v e d w i t h o u t ECMO, PC was s t o p p e d a t 5 . 3 (3-10.5) d a n d v e n t i l a t o r t h e r a p y a t 7 . The effect of surfactants In treatment of neonatal RDS 1s well known However, the favourable results lncrease the demand for neonalal lnteslve care We collected retrospectively cllnlcal and follow-up dale of all 29 very low b~rlhwe~ght (VLBW) Infants who rece~ved surfactant In the OSlRlS study (from March 1991 to November 1991) and of 30 VLBW patlents born durtng the prevlous year who dld not recelve surfactant treatment Patlents were eltg~ble lo the control group 11 they had at least once arter3/alveolar oxygen ratlo cO 22
The gestational age, blrlhwelght and blood pressure were slm~lar In both groups
Only 6 lnfants In the control group survlved and only 2 of lhem d~d no1 have any neurolog~cal sequelae In the OSlRlS group 20 Survived 9 w~thout neurolog~cal compllcallons The mean duratlon of neonatal lntenslva care was 10 2 days In the controll group and 26 8 days In the OSlRlS group The mean duratlon of neonatal lnlenslve care of the survivors was 32 days In bolh groups A slm~lar effect was observed on the time on respirator, and on the durat~on of oxygen therapy and ol hospltal care
The costs of neonalal lntenslve care were In 1992 about 1500 US$ and the cost for care on a paed~atrlc ward were about 400 US$ per day Thus glvlng a VLBW ~nfant surfactant will Increase the costs wlth al least 36 000 US$ The costs per survlvor were wlthout surfaclant about 3110 US$ and w~th surfactanl 2730 US$ The costs per healthy survlvor were 9330 US$ and 6670 US$, respectrvely Thls study illustrates the econom~cal problems assoc~ated wtth lrnprovments of neonatal ~ntens~ve care Although the prlce per survivor decreases the Increase of total costs IS very larqe The prlce of surfaclant ~tself IS almost neoltaible
